“(III) burden of asthma on disproportionately affected areas, particularly those in medically underserved populations (as defined in section 330(b)(3)); and
」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」」＜第２章　物質の構成粒子＞（教p19-）